Miami, Florida
Phase 1 cancer trials in Miami, FL
47 Phase 1 cancer studies are recruiting participants at sites in Miami as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Miami at a glance
- 47 studies are recruiting at a site in Miami.
- By phase: Early Phase 1 (1), Phase 1 (19), Phase 1/2 (27).
- By sponsor: industry (38), university, hospital or other (6), government (3).
- By research area: Lymphoma (16), Breast Cancer (13), Lung Cancer (7), Prostate Cancer (6), Melanoma (3), Pancreatic Cancer (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Miami
Basic details from each study's public record (the 30 most recently updated of 47). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- University of Miami
- Registry record
- NCT06253871 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Miami Cancer Institute
- Registry record
- NCT07488676 · updated
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Phase 1
- Ages 18 to 55
- Female participants
- Sponsor
- TerSera Therapeutics LLC
- Study site
- Regis Clinical Research
- Registry record
- NCT07310420 · updated
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- Sylvester Comprehensive Cancer Center
- Registry record
- NCT07100106 · updated
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ModeX Therapeutics, An OPKO Health Company
- Study site
- Sylvester Comprehensive Cancer Center - University of Miami Health System
- Registry record
- NCT06239194 · updated
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- University of Miami
- Registry record
- NCT06293898 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- University of Miami - Sylvester Comprehensive Cancer Center
- Registry record
- NCT04585750 · updated
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- University of Miami Hospital and Clinics, Sylvester Cancer Center
- Registry record
- NCT06618287 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Lung cancer studies recruiting in Miami
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- University of Miami
- Registry record
- NCT06444815 · updated
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Obsidian Therapeutics, Inc.
- Study site
- University of Miami
- Registry record
- NCT06060613 · updated
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Biogenix Molecular, LLC
- Registry record
- NCT07887971 · updated
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111)
- Registry record
- NCT06780137 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #47
- Registry record
- NCT05176483 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Prostate cancer studies recruiting in Miami
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Biogenix Molecular, LLC
- Registry record
- NCT07581184 · updated
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- K36 Therapeutics, Inc.
- Study site
- Sylvester Comprehensive Cancer Center
- Registry record
- NCT07103018 · updated
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06879041 · updated
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 to 99
- Male participants
- Sponsor
- AstraZeneca
- Registry record
- NCT07590934 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Melanoma studies recruiting in Miami
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT05896839 · updated
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- University of Miami
- Registry record
- NCT05655312 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Miami, FL on ClinicalTrials.gov.
Lymphoma studies recruiting in Miami
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Nicklaus Children's Hospital
- Registry record
- NCT04726241 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- University of Miami; Sylvester Cancer Center
- Registry record
- NCT05384626 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Miami - Sylvester Cancer Center
- Registry record
- NCT07226843 · updated
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- University of Miami Miller School of Medicine
- Registry record
- NCT04139304 · updated
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT06860594 · updated
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT07332507 · updated
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06137144 · updated
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BeOne Medicines
- Study site
- Mount Sinai Medical Center Braman Comprehensive Cancer Center
- Registry record
- NCT05006716 · updated
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- TORL Biotherapeutics, LLC
- Study site
- University of California Miami, Sylvester Comprehensive Cancer Center
- Registry record
- NCT07439653 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Miami, FL on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Miami
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study sites
- Biogenix · University of Miami
- Registry record
- NCT06710756 · updated
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- PanTher Therapeutics
- Study site
- University of Miami Sylvester Cancer Center
- Registry record
- NCT06673017 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Ask about studies near Miami
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
240 studies recruiting across 42 cities.
Tampa
74 studies recruiting.
Jacksonville
47 studies recruiting.
Sarasota
45 studies recruiting.
Orlando
41 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections